Phase II, multicenter, randomized, open-label study of DS-7300 in patients (pts) with pre-treated extensive-stage small cell lung cancer (ES-SCLC) Meeting Abstract


Authors: Paz-Ares, L.; Johnson, M. L.; Girard, N.; Hann, C. L.; Ahn, M. J.; Nishio, M.; Godard, J.; Laadem, A.; Yoshizuka, N.; Qian, M.; Cheng, B.; Rudin, C. M.
Abstract Title: Phase II, multicenter, randomized, open-label study of DS-7300 in patients (pts) with pre-treated extensive-stage small cell lung cancer (ES-SCLC)
Meeting Title: ESMO Congress 2022
Journal Title: Annals of Oncology
Volume: 33
Issue: Suppl. 7
Meeting Dates: 2022 Sep 9-13
Meeting Location: Paris, France
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2022-09-01
Start Page: S1255
End Page: S1256
Language: English
ACCESSION: WOS:000866211602102
DOI: 10.1016/j.annonc.2022.07.1644
PROVIDER: wos
Notes: Meeting Abstract: 1550TiP -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Charles Rudin
    488 Rudin